
Covid vaccine: Single dose vaccine 66% effective
Belgian company Janssen says its Covid-19 vaccine is 66% effective
We bring you today鈥檚 developments and answer audience questions on Covid-19 vaccines, after encouraging results from the trials of two new vaccines. The Belgian pharmaceutical company Janssen, owned by Johnson & Johnson, has announced that a single dose of its vaccine prevents 66% of Covid cases. Also, a new Novavax vaccine has been shown to be 89.3% effective in large-scale trials in the UK. And the EU's drugs regulator has approved the use of the AstraZeneca Covid vaccine for people aged over 18.
We also speak to parents about the challenges of parenting and home schooling during lockdown.
And we hear from people in Lebanon who have been protesting against a strict coronavirus lockdown.
(Photo: Screengrab taken from undated video issued by Johnson and Johnson showing vials of the Janssen COVID-19 vaccine. Credit: Janssen Pharmaceutical Companies/PA Wire)
Last on
Broadcast
- Fri 29 Jan 2021 16:06GMT成人快手 World Service
Sexual Harassment
People's experiences of inappropriate behaviour
Trump's Towns
Perspectives from and reaction to President Trump's core supporters
Refugee Stories
The experiences of refugees building new lives
At the heart of the story
Bringing you the latest on the news stories that matter
Telling my story
Stories, memories and experiences that changed lives